Z
Zhejiang Taimei Medical Technology
Biotech & Life Sciences · Huangpu, China · Founded 2013 · IPO 2024
A cloud platform for clinical research collaboration MoreLess
Zhejiang Taimei Medical Technology Co., Ltd. operates as a digital solutions provider for the life science industry, with a strategic focus on the pharmaceutical and medical device sectors in China. Founded by Zhao Lu in June 2013, the company aims to enhance the research and development (R&D) and commercialization processes for its clients. Zhao Lu, who serves as the company's chairman, is the largest shareholder.
Taimei Technology's business model is centered on providing cloud-based, software-as-a-service (SaaS) products, eliminating the need for clients to install and maintain software on-premise. The company generates revenue through the sale of these self-developed SaaS products and by offering related professional services in the fields of clinical research, pharmacovigilance, and pharmaceutical marketing. Its clientele includes pharmaceutical companies, contract research organizations (CROs), and research institutes. By March 2024, Taimei had served over 1,400 pharmaceutical firms and CROs, including 21 of the top 25 global pharmaceutical companies.
The company's core offering is its TrialOS platform, a digital collaboration hub designed to connect key industry stakeholders such as pharmaceutical companies, hospitals, service providers, regulatory bodies, and patients. This platform facilitates data exchange and process cooperation by leveraging artificial intelligence, big data, and mobile internet technologies. In addition to TrialOS, the company offers PharmaOS, a digital marketing platform that integrates omnichannel marketing systems to provide data-driven solutions for sales management and customer targeting. Taimei also provides over 40 distinct software products and digital services, including solutions for clinical trial management, data collection and analysis, and pharmacovigilance. These offerings support the entire drug product lifecycle, from R&D to post-market activities.
Keywords: life sciences digital platform, clinical research software, pharmacovigilance solutions, pharmaceutical marketing, SaaS for pharma, TrialOS platform, drug development technology, clinical trial management, medical device R&D solutions, contract research organization services, digital health China, eClinical solutions, Zhao Lu, data-driven healthcare, healthcare IT, pharmaceutical commercialization, medical data management, cloud-based healthcare software, regulatory compliance software, PharmaOS
Talent graph
Zhejiang Taimei Medical Technology's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Zhejiang Taimei Medical Technology has talent and traffic
team presence
Patent intelligence
$12M patent portfolio · 230 active families
Where Zhejiang Taimei Medical Technology concentrates vs peers
Each axis is a top-10 topic across Zhejiang Taimei Medical Technology and its closest peers. #1 = 100, #10 = 10, absent = 0.
Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.
Market sentiment
What the market is saying about Zhejiang Taimei Medical Technology
An AI-synthesized read of the highest-engagement posts about Zhejiang Taimei Medical Technology on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Zhejiang Taimei Medical Technology on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.